Solid Therapeutic Hierarchy for EoE Still Unclear
Most available drugs for eosinophilic esophagitis (EoE) demonstrate greater efficacy than placebo, but data are too heterogenous to determine a reliable therapeutic hierarchy.
Stay updated with breaking news from Task Force On Allergy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Most available drugs for eosinophilic esophagitis (EoE) demonstrate greater efficacy than placebo, but data are too heterogenous to determine a reliable therapeutic hierarchy.
Press release content from Business Wire. The AP news staff was not involved in its creation. Eosinophilic Esophagitis Epidemiology Forecast to 2030 - ResearchAndMarkets.com April 28, 2021 GMT This ‘Eosinophilic Esophagitis (EoE) - Epidemiology Forecast - 2030’ report delivers an in-depth understanding of the historical and forecasted epidemiology of EoE in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Eosinophilic Esophagitis: Epidemiology The EoE epidemiology division provides insights about the historical and current patient pool, along with...